Alerts will be sent to your verified email
Verify Email
AUROLAB
|
Auro Laboratories
|
Tyche Inds
|
Vaishali Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.74 % | 14.86 % | 7.61 % |
|
5yr average Equity Multiplier
|
1.68 | 1.18 | 2.76 |
|
5yr Average Asset Turnover Ratio
|
1.03 | 0.6 | 0.89 |
|
5yr Avg Net Profit Margin
|
9.45 % | 20.15 % | 3.52 % |
|
Price to Book
|
3.44 | 1.08 | 2.3 |
|
P/E
|
212.13 | 12.19 | 375.0 |
|
5yr Avg Cash Conversion Cycle
|
34.28 Days | 86.71 Days | 133.52 Days |
|
Inventory Days
|
40.18 Days | 61.45 Days | 6.09 Days |
|
Days Receivable
|
87.78 Days | 108.17 Days | 217.95 Days |
|
Days Payable
|
76.54 Days | 93.08 Days | 174.07 Days |
|
5yr Average Interest Coverage Ratio
|
12.13 | 2385.83 | 2.44 |
|
5yr Avg ROCE
|
20.0 % | 19.65 % | 16.76 % |
|
5yr Avg Operating Profit Margin
|
14.46 % | 23.57 % | 6.18 % |
|
5 yr average Debt to Equity
|
0.3 | 0.0 | 0.6 |
|
5yr CAGR Net Profit
|
13.98 % | -6.96 % | 88.82 % |
|
5yr Average Return on Assets
|
9.66 % | 12.43 % | 3.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.18 % | 61.97 % | 26.32 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | 0.0 | -0.42 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Auro Laboratories
|
Tyche Inds
|
Vaishali Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|